ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
C00-D49: Neoplasms |
Head and neck cancer |
C07-C14, C32-C33 |
AKR1B1 |
I00-I99: Diseases of the circulatory system |
Heart failure |
I50 |
ADRA2C |
K00-K95: Diseases of the digestive system |
Duodenal ulcers |
K25-K27 |
CA1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
GPBAR1; HSD11B1 |
A00-B99: Certain infectious and parasitic diseases |
Helminth infection |
A00-B99 |
ACHE |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Poisoning due to pesticides and chemicals |
T36-T50 |
ACHE |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic cataract |
E10.36, E11.36 |
AKR1B1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Fibromyalgia |
M79.7 |
ADRA2C |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Poison intoxication |
T36-T50 |
ADRA2C; ACHE |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Arthritis |
M00-M25 |
PLA2G1B; ABCC1 |
I00-I99: Diseases of the circulatory system |
Arteriosclerosis |
I70 |
PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Hypercholesterolemia |
E78 |
HSD11B1 |
I00-I99: Diseases of the circulatory system |
Hypertension |
I10-I16 |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Pompe's disease |
E74.02 |
GAA |
A00-B99: Certain infectious and parasitic diseases |
Fungal infections |
B35-B49 |
RAB9A |
I00-I99: Diseases of the circulatory system |
Hypotension |
I95 |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Lipid metabolism disorder |
E75-E78 |
HSD11B1 |
A00-B99: Certain infectious and parasitic diseases |
Infections |
A00-B99 |
PTPN1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Mild cognitive impairment |
F06.7 |
ACHE |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
CA1; CA9; MAPK1; ACHE; CDC25B |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
CA9; MAPK1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Sexual dysfunction |
F52 |
ADRA2A |
J00-J99: Diseases of the respiratory system |
Allergic rhinitis |
J00, J30, J31.0, T78.4 |
ADRA2C; PLA2G1B |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Allergy |
T78.4 |
PLA2G1B |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
ADRA2C; ACHE; ACHE; ACHE |
A00-B99: Certain infectious and parasitic diseases |
Visceral leishmaniasis |
B55.0 |
PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Attention deficit hyperactivity disorder |
F90 |
ADRA2A |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Alcohol use disorders |
F10.2 |
ADRA2C |
C00-D49: Neoplasms |
Breast cancer |
C50 |
CA9 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic syndrome x |
E88.81 |
HSD11B1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Rheumatoid arthritis |
M05-M06 |
AKR1B1; PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
ACHE |
K00-K95: Diseases of the digestive system |
Xerostomia |
K11.7, R68.2 |
ACHE |
I00-I99: Diseases of the circulatory system |
Restenosis |
I51.89 |
MAPK1 |
C00-D49: Neoplasms |
Renal cancer |
C64 |
CA9 |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
ADRA2C; ADRA2A; ACHE |
G00-G99: Diseases of the nervous system G00-G99 |
Parkinson's disease |
G20 |
ACHE |
A00-B99: Certain infectious and parasitic diseases |
Pediculus humanus capitis |
B85.0 |
ACHE |
K00-K95: Diseases of the digestive system |
Peptic ulcer |
K25-K27 |
ADRA2C |
C00-D49: Neoplasms |
Clear cell renal cell carcinoma |
C64 |
CA9 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Cognitive disorders |
F01-F07, F04, F05, R41.3 |
ACHE |
H00-H59: Diseases of the eye and adnexa |
Ocular hypertension |
H40.0 |
HSD11B1; ADRA2C |
H00-H59: Diseases of the eye and adnexa |
Ocular disease |
H00-H59 |
ADRA2C |
H00-H59: Diseases of the eye and adnexa |
Open-angle glaucoma |
H40-H42 |
ACHE |
H00-H59: Diseases of the eye and adnexa |
Chronic glaucoma |
H40-H42 |
CA1; ACHE |
L00-L99: Diseases of the skin and subcutaneous tissue |
Pruritus |
L29 |
PLA2G1B |
G00-G99: Diseases of the nervous system G00-G99 |
Neurodegenerative disease |
G30-G32 |
ACHE |
I00-I99: Diseases of the circulatory system |
Neurological disease |
I21, I22, R52, R52.1-R52.2, R60.9, G89 |
ADRA2C |
NA: NA |
Early satiation associated with functional dyspepsia |
NA |
ACHE |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
ADRA2C; PLA2G1B |
E00-E89: Endocrine, nutritional and metabolic diseases |
Type 2 diabetes |
E11 |
PTPN1; PTPN1; GPBAR1; HSD11B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic complication |
E08-E13 |
AKR1B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic nephropathy |
E11.21 |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
AKR1B1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
PTPN1; HSD11B1; ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Non-insulin dependent diabetes |
E11.9 |
HSD11B1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses |
L20-L30 |
PLA2G1B |
L00-L99: Diseases of the skin and subcutaneous tissue |
Inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp |
L20-L30 |
PLA2G1B |
C00-D49: Neoplasms |
Inflammatory disease |
C11, C44, K75.9, M00-M25 |
PLA2G1B |
J00-J99: Diseases of the respiratory system |
Influenza virus |
J11.1 |
HSD11B1 |
NA: NA |
Upper abdominal bloating |
NA |
ACHE |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Depression |
F30-F39 |
ADRA2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
PTPN1; HSD11B1; HSD11B1; AKR1B1 |
M00-M99: Diseases of the musculoskeletal system and connective tissue |
Gout |
M10 |
AKR1B1; ABCC1; ABCC1 |
G00-G99: Diseases of the nervous system G00-G99 |
Myasthenia gravis diagnosis |
G70.0 |
ACHE |
G00-G99: Diseases of the nervous system G00-G99 |
Myasthenia gravis |
G70.0 |
ACHE |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Contusion |
S36.220S |
ADRA2C |
C00-D49: Neoplasms |
Lymphoma |
C81-C86 |
CA9 |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Nerve injury |
T14.4 |
PLA2G1B |
A00-B99: Certain infectious and parasitic diseases |
Leishmaniasis |
B55.0 |
PLA2G1B |
N00-N99: Diseases of the genitourinary system |
Urinary dysfunction |
N39.3-N39.4 |
ACHE |
I00-I99: Diseases of the circulatory system |
Atherosclerosis |
I70 |
HSD11B1 |
H00-H59: Diseases of the eye and adnexa |
Glaucoma |
H40-H42 |
CA1; CA1; AKR1B1; ADRA2C; ACHE |
L00-L99: Diseases of the skin and subcutaneous tissue |
Erythema |
L51-L54 |
ADRA2C |
G00-G99: Diseases of the nervous system G00-G99 |
Epileptic seizures |
G40, P90, R56 |
ACHE |
NA: NA |
Colour dead tissues |
NA |
PTPN1 |
L00-L99: Diseases of the skin and subcutaneous tissue |
Contact dermatitis |
L23, L24, L25 |
PLA2G1B |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Male sexual disorders |
F52 |
ADRA2C |